The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life Study.
Nadiye AkdenizMuhammet Ali KaplanMevlüde İnançDoğan UncuYakup ErgünMehmet KüçükönerAyşe DemirciMehmet Ali Nahit ŞendurMehmet BeşiroğluAtakan TopçuHalis YerlikayaZuhat UrakçiSaadettin KiliçkapAbdurrahman IşikdoğanPublished in: Pancreas (2023)
In our study, FFX regimen provides a significant advantage over the other treatment regimens in terms of response rates and survival. Treatment toxicity was more frequent but manageable with the FFX regimen.